![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KF Heim, G Thomas and PW Ramwell
Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC.
Superoxide anion (O2-) blocks the vascular effect of endothelium- derived relaxing factor (EDRF). Previous reports implicate L-arginine or N alpha-substituted arginine compounds as precursors of EDRF. Employing a microassay for the measurement of O2- production by rabbit aortic rings, which is based on the established method of reduction of cytochrome c by O2-, we studied the interaction between O2- and EDRF using L-arginine, an N-substituted arginine compound, namely, N alpha- benzoyl-L-arginine ethyl ester (BAEE), sodium nitroprusside and NG- monomethyl-L-arginine (NMMA), a putative specific inhibitor of EDRF synthesis. Measurements of O2- production were made under basal conditions and upon stimulation with alloxan, the diabetogenic, O(2-)- generating compound. Both BAEE, an EDRF-generating agent (0.3 and 3.0 mM) and sodium nitroprusside, an NO-generating compound (1.7 and 3.4 microM), significantly reduced alloxan-stimulated O2- production, but L- arginine (0.6-3.0 mM) paradoxically increased O2- generation. NMMA (1.0 mM) blocked the inhibitory effect of BAEE on O2- production in an endothelium-dependent manner. Because NMMA is an inhibitor of EDRF, these results suggest that BAEE, but not L-arginine, reduces O2- produced by the endothelium of the rabbit aorta through a mechanism involving EDRF generation.
This article has been cited by other articles:
|
|
 |
|
  S. Nakata, M. Tsutsui, H. Shimokawa, O. Suda, T. Morishita, K. Shibata, Y. Yatera, K. Sabanai, A. Tanimoto, M. Nagasaki, et al. Spontaneous Myocardial Infarction in Mice Lacking All Nitric Oxide Synthase Isoforms Circulation, April 29, 2008; 117(17): 2211 - 2223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Suda, M. Tsutsui, T. Morishita, H. Tasaki, S. Ueno, S. Nakata, T. Tsujimoto, Y. Toyohira, Y. Hayashida, Y. Sasaguri, et al. Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase-Deficient Mice: Involvement of Renin-Angiotensin System and Oxidative Stress Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1682 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Suda, M. Tsutsui, T. Morishita, A. Tanimoto, M. Horiuchi, H. Tasaki, P. L. Huang, Y. Sasaguri, N. Yanagihara, and Y. Nakashima Long-Term Treatment With N{omega}-Nitro-L-Arginine Methyl Ester Causes Arteriosclerotic Coronary Lesions in Endothelial Nitric Oxide Synthase-Deficient Mice Circulation, September 24, 2002; 106(13): 1729 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Behr-Roussel, A. Rupin, S. Simonet, E. Bonhomme, S. Coumailleau, A. Cordi, B. Serkiz, J.-N. Fabiani, and T. J. Verbeuren Effect of Chronic Treatment With the Inducible Nitric Oxide Synthase Inhibitor N-Iminoethyl-L-Lysine or With L-Arginine on Progression of Coronary and Aortic Atherosclerosis in Hypercholesterolemic Rabbits Circulation, August 29, 2000; 102(9): 1033 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Gobbel, T. Y.-Y. Chan, and P. H. Chan Nitric Oxide- and Superoxide-Mediated Toxicity in Cerebral Endothelial Cells J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1600 - 1607. [Abstract] [Full Text]
|
|
|
|
|
|
P. S. Tsao, R. Buitrago, J. R. Chan, and J. P. Cooke Fluid Flow Inhibits Endothelial Adhesiveness: Nitric Oxide and Transcriptional Regulation of VCAM-1 Circulation, October 1, 1996; 94(7): 1682 - 1689. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
